Owkin's new insights into the opportunities and challenges for digital pathology and AI solutions
17 December 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.